Estimating Risk Reduction Required to Break even in a Health Promotion Program

American Journal of Health Promotion

Volumn 18, Issue 4, 2004, Pages 316-325

  Ozminkowski, Ronald J ^a,g   Goetzel, Ron Z ^b,c   Santoro, Jan ^d   Saenz, Betty Jo ^e   Eley, Christine ^e   Gorsky, Bob ^f  

^a Medstat   (United States)

^b Cornell University ^*  (United States)

^c Department of Obstetrics Gynecology   (United States)

^d Medstat   (United States)

^e MOTOROLA INC   (United States)

^f NONE   (United States)

^g MEDSTAT GROUP   (United States)

Author keywords

Cost; Economics; Health Promotion; Health Risk; Prevention Research; Return on Investment; Wellness

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DEPRESSION; EATING HABIT; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INVESTMENT; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HEALTH; RISK ASSESSMENT; SMOKING HABIT; STRESS; WELLBEING;

EID: 1542363473     PISSN: 08901171     EISSN: None     Source Type: Journal    
DOI: 10.4278/0890-1171-18.4.316     Document Type: Article

References (12)

1. Centers for Disease Control. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47:RR-19.
2. Goetzel RZ, Anderson DW, Whitmer RW, et al. The relationship between modifiable health risks and health care expenditures: an analysis of the multi-employer HERO health risk and cost database. J Occup Environ Med. 1998;4:843-857.
3. Ozminkowski RJ, Mark TL, Goetzel RZ, et al. Relationships between substance use, medical expenditures, and the occurrences of injuries at a large manufacturing firm. Am J Drug Alcohol Abuse. 2003;29:151-167.
4. Reynolds C. The health and productivity management movement (HPM)-three key insights, one radical conclusion. Employer Health Management eNews. June 2001.
5. Leutzinger JA, Ozminkowski RJ, Dunn RL, et al. Projecting future medical care costs using four scenarios of lifestyle risk rates. Am J Health Promot. 2000;15:35-44.
6. Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions. Med Care. 1993;31:403-418.
7. Nas T. Cost-Benefit Analysis. Thousand Oaks, CA: Sage; 1996.
8. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
9. Gramlich EM. A Guide to Benefit-cost Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall; 1990.
10. Goetzel RZ. The Role of Business in Improving the Health of Workers and the Community. Washington, DC: National Academy of Sciences (NAS); 2001.
11. Edington DW. Emerging research: a view from one research center. Am J Health Promot. 2001;15:341-349.
12. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605-611.